ProQR Therapeutics N.V. (PRQR) Financials

PRQR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 113.6 million 70.5 million
Dec. 31, 2025 132.3 million 74.4 million
Sept. 30, 2025 145.9 million 79.0 million
June 30, 2025 162.1 million 83.2 million

PRQR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.2 million 1.6 million
Dec. 31, 2025 -16.0 million 1.4 million
Sept. 30, 2025 -14.6 million 1.3 million
June 30, 2025 -13.6 million 1.1 million

PRQR Net Income

No data available :(

PRQR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 93.0 million - 10.4 million
Dec. 31, 2025 108.4 million - 11.2 million
Sept. 30, 2025 125.4 million - 13.7 million
June 30, 2025 141.2 million - 14.3 million

PRQR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 120.7 million
Dec. 31, 2025 120.9 million
Sept. 30, 2025 129.2 million
June 30, 2025 124.2 million

PRQR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 191028 13.8 million 3.7 million -
Dec. 31, 2025 609400 11.5 million 3.7 million -
Sept. 30, 2025 198326 13.0 million 3.7 million -
June 30, 2025 119044 13.4 million 5.7 million -

PRQR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.4 million 808374
Dec. 31, 2025 5.5 million 789644
Sept. 30, 2025 3.4 million -
June 30, 2025 4.5 million -

PRQR

Price: $1.50

52 week price:
1.33
3.10

Earnings Per Share: -0.50 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 1.0 million

Ebitda: -11.0 million

Market Capitalization: 161.2 million

Links: